Morphic Holding (MORF) Financials

$56.99

$0.00 (0.00%)

As on 16-Aug-2024 09:30EDT

Market cap

$2,862 Mln

Revenue (TTM)

$-60 Mln

P/E Ratio

--

P/B Ratio

4.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	-60.24	0.52	70.81	19.79	44.95	16.98
Cost of Revenue	1.12	1.09	1.00	1.03	73.63	53.73
Gross Profit	-61.36	-0.57	70.81	19.79	44.95	-36.76
Operating Expenses	212.46	179.21	134.20	115.60	92.13	63.97
Operating Profit (EBIT)	-213.02	-178.69	-63.40	-95.81	-47.18	-46.99
Other Income	--	--	--	--	1.61	--
Profit before Tax	-179.30	-151.72	-58.97	-95.54	-45.57	-42.42
Provision for Tax	0.36	0.38	0.07	-1.30	-0.57	0.91
Profit after Tax (Net Income)	-179.83	-152.10	-59.04	-94.24	-45.00	-43.33
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-59.04	-95.54	-45.00	-43.33

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	618.43	697.02	349.12	336.70	145.20	140.92
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.16	0.72	2.34	51.33	57.75	71.17
Current Liabilities	26.51	24.78	17.13	38.26	39.44	35.35
Total Liabilities	672.60	722.51	368.59	426.29	242.38	247.44

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	6.59	5.59	6.41	7.96	2.95	3.86
Current Assets	639.50	716.93	362.18	418.33	239.44	243.57
Total Assets	672.60	722.51	368.59	426.29	242.38	247.44
Total Debt*	3.32	2.34	3.84	5.05	--	--
Net Current Assets	612.99	692.15	345.06	380.07	200.00	208.22

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-112.31	-100.98	-83.46	-45.99	-41.65
Cash Flow from Investing Activities	--	--	-56.45	-113.18	8.18	-135.99
Cash from Financing Activities	--	453.43	45.27	266.31	38.30	93.30
Net Cash Inflow / Outflow	--	--	--	--	0.49	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-3.75	-3.62	-1.55	-2.62	-1.45	-2.71
Cash EPS ($)	--	-3.60	-1.53	-2.59	-1.42	-2.66
Adjusted Book Value ($)	--	16.60	9.19	9.35	4.68	8.81
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.67	-2.66	-2.32	-1.48	-2.60
Free Cash Flow per Share ($)	--	-2.70	-2.67	-2.35	-1.50	-2.74

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-28.91	-17.00	-38.71	-31.46	-98.06
ROE (%)	-27.34	-29.08	-17.22	-39.11	-31.46	-98.06
ROA (%)	-24.99	-27.88	-14.86	-28.19	-18.37	-19.84
EBIT Margin (%)	354.11	-34,296.74	-89.53	-484.02	-104.97	-276.77
Net Margin (%)	298.54	-29,192.90	-83.38	-476.10	-96.66	-255.22
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-187.37	-0.99	2.58	-0.56	1.65	4.06
EBIT Growth (%)	-49.05	-181.86	33.83	-103.06	-0.41	-90.79
Net Profit Growth (%)	-38.81	-157.61	37.35	-109.43	-3.86	-81.81
EPS Growth (%)	-14.95	-1.33	0.41	-0.80	0.46	--
Book Value Growth (%)	-28.78	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-7.98	-17.22	-18.10	-23.11	-6.34
Price / Book Value	4.63	1.74	2.91	5.07	7.16	1.95
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-25.33	-2.88	-10.77	-11.25	-14.89	-0.81
Close Price ($)	34.07	28.88	26.75	47.38	33.55	17.16
High Price ($)	62.08	63.08	52.34	93.00	36.65	33.50
Low Price ($)	19.35	19.35	19.23	29.21	9.90	12.03
Market Cap ($ Cr)	2,862.31	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.00	0.01	0.01	--	--
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.20	--
Current Ratio	24.13	28.94	21.15	10.93	6.07	6.89
Quick Ratio	24.13	--	21.17	10.99	6.26	--
Interest Coverage	-52.38	--	-13.88	-352.23	-17.24	-10.28

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	0.64	11.66	16.27	20.42
Asset Turnover	-0.08	0.00	0.18	0.06	0.18	0.08
Receivable days	--	159.49	7.12	88.77	43.81	37.30
Inventory Days	--	-152.33	-501.90	-1,705.86	-36.28	--
Payable days	--	1,870.27	1,503.34	1,532.45	22.35	23.49
Cash Conversion Cycle	--	-1,863.11	-1,998.12	-3,149.55	-14.83	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.